Michał Wroński

Dr. Michał Wroński

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2021 in Progress in Neuro-Psychopharmacology and Biological Psychiatry
Verified
Journal Article
Closed access
PLPaweł Liśkiewicz
Paweł Liśkiewicz
MKMariusz Kaczmarczyk
Mariusz Kaczmarczyk
Blazej MisiakBlazej Misiak
Blazej Misiak
MWMichał Wroński
Michał Wroński
ABAgata Bąba-Kubiś
Agata Bąba-Kubiś
JSJerzy Sanochowiec
Jerzy Sanochowiec

3 October 2019 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
JPJustyna Pełka-Wysiecka
Justyna Pełka-Wysiecka
MKMariusz Kaczmarczyk
Mariusz Kaczmarczyk
ABAgata Bąba-Kubiś
Agata Bąba-Kubiś
PLPaweł Liśkiewicz
Paweł Liśkiewicz
MWMichał Wroński
Michał Wroński
JSJerzy Sanochowiec
Jerzy Sanochowiec
Accumulating evidence indicates the potential effect of microbiota on the pathogenesis and course of schizophrenia. However, the effects of olanzapine, second-generation antipsychotics, on gut microbiota have not been investigated in humans. This study aimed to analyze fecal microbiota in schizophrenia patients treated with olanzapine during six weeks of their hospital stay. After a seven-day washout from all psychotropic medications, microbiota compositions were evaluated at baseline and after six weeks of hospitalization using 16S rRNA sequencing. The study was conducted in 20 inpatients, who followed the same hospital routine and received 5–20 mg daily doses of olanzapine. Olanzapine treatment was associated with clinical improvements in all patients and significant increases in body mass index in females, but not changes in gut microbiota compositions and predicted function. The severity of symptoms at the beginning of treatment varied in accordance with the predicted metabolic activity of the bacteria. The present findings indicate that the microbiota of schizophrenia patients is highly individual and has different taxonomical (Type 1, with a predominance of Prevotella, and Type 2 with a higher abundance of Bacteroides, Blautia and Clostridium) and functional clusters, and it does not change following six weeks of olanzapine therapy; in addition, the microbiota is not associated with either the weight gain observed in women or the effectiveness of olanzapine therapy.

1 February 2019 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
PLPaweł Liśkiewicz
Paweł Liśkiewicz
JPJustyna Pełka-Wysiecka
Justyna Pełka-Wysiecka
MKMariusz Kaczmarczyk
Mariusz Kaczmarczyk
IŁIgor Łoniewski
Igor Łoniewski
MWMichał Wroński
Michał Wroński
JSJerzy Sanochowiec
Jerzy Sanochowiec
Rationale: There is a worldwide prevalence of generalized anxiety and major depressive disorders (MDD). Gut–brain axis dysfunction, antibacterial activity, and modulatory effects of antidepressants toward intestinal bacteria have been shown both in vitro and in vivo. Objectives: In this study, we aimed to investigate the effects of hospital stay, including escitalopram administration, on gut microbiota in patients with depressive episodes. Methods: After admission to the hospital and 7-days washout from all medications the composition of fecal microbiota samples was evaluated at baseline (W0) and after 6 weeks (W6), using 16S rRNA sequencing. The study was conducted on 17 inpatients (52.9% females), who followed the same daily hospital routine, including a standard diet and received 5–20 mg daily doses of escitalopram. Results: At the end of treatment (W6), no change was observed in the Chao1 index. However, Shannon (median (Q1–Q3): W0 2.78 (2.67–3.02) vs. W6 3.11 (2.80–3.30)), and inverse Simpson (median (Q1–Q3): W0 9.26 (7.26–13.76) vs. W6 12.13 (9.17–15.73)) indices increased significantly compared to baseline values (False Discovery Rate p (q) = 0.031 and q = 0.011, respectively). We also found that between-subject W0 Bray–Curtis dissimilarities were significantly higher than W0–W6 within-subject dissimilarities (median (Q1–Q3): 0.68 (0.56–0.77) vs. 0.38 (0.35–0.52), two sided Mann–Whitney test p < 0.00001. The within-subject dissimilarities did not depend on sex, age, BMI, illness duration and a daily dose of escitalopram. No significant differences between taxa levels, at the studied time points, were observed when adjusted for multiple hypotheses testing procedures. Conclusions: We conclude that a six-week treatment in a psychiatric hospital setting resulted in increased alpha biodiversity in fecal microbiota, however its causal relationship with patients’ mental health was not proved. We have also found that individual microbiome stability was not affected by hospitalization.

15 December 2006 in Alcohol and Alcoholism
Verified
Journal Article
Open access
PDF file
MWMichał Wroński
Michał Wroński
DSDominika Skrok-Wolska
Dominika Skrok-Wolska
JSJerzy Sanochowiec
Jerzy Sanochowiec
MZMarcin Ziolkowski
Marcin Ziolkowski
ŁSŁukasz Swiecicki
Łukasz Swiecicki
ASAnna Scinska
Anna Scinska
Aims: The aim of the present study was to evaluate a possible relationship between taste responses to sweet solutions and alcoholic status. Methods: The rated intensity and pleasantness of sucrose taste was compared in male alcoholics (n = 45) and non-alcoholic controls (n = 33). Results: The rated intensity, but not pleasantness, of water taste (0% sucrose) was higher in the alcoholics. The two groups did not differ with respect to the rated intensity or pleasantness of sucrose solutions (1–30%). The proportion of sweet-likers, i.e. subjects rating 30% sucrose as most pleasant, was similar in both groups (the controls: 57.6%, the alcoholics: 62.2%). A subgroup of alcoholics with a paternal history of alcoholism (n = 22) rated the highest sucrose concentration as more pleasant compared to alcoholics without alcoholic fathers. The proportion of sweet-likers among the alcoholics with a paternal history of alcoholism (77.3%) was significantly higher than that found in the alcoholics without a familial history of alcoholism (47.8%). Conclusions: The present results suggest the following: (i) alcohol dependence is not associated with any major alterations in taste responses to sucrose solutions, (ii) sweet liking is a phenotypic marker of male alcoholics with a paternal history of alcoholism.

1 September 2013 in Pharmacological Reports
Verified
Journal Article
Closed access
JPJustyna Pełka-Wysiecka
Justyna Pełka-Wysiecka
MWMichał Wroński
Michał Wroński
AJAndrzej Jasiewicz
Andrzej Jasiewicz
AGAnna Maria Grzywacz
Anna Maria Grzywacz
PTPiotr Tybura
Piotr Tybura
JSJerzy Sanochowiec
Jerzy Sanochowiec

1 October 2018 in Psychoneuroendocrinology
Verified
Journal Article
Closed access
Blazej MisiakBlazej Misiak
Blazej Misiak
KKKamila Kotowicz
Kamila Kotowicz
OLOlga Loska
Olga Loska
FSFilip Stramecki
Filip Stramecki
JBJan Aleksander Beszłej
Jan Aleksander Beszłej
PPPatryk Piotrowski
Patryk Piotrowski